http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010526809-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4188 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19 |
filingDate | 2008-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2010-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2010526809-A |
titleOfInvention | Methods of treatment using intravenous formulations containing temozolomide |
abstract | The present invention relates to methods and formulations for treating proliferative disorders using intravenous formulations containing temozolomide over a specified period of time. These methods and formulations are particularly suitable for patients who cannot swallow oral formulations. These methods and formulations also provide additional convenience to patients already receiving other treatments. In some embodiments, the method may comprise a carcinoma, sarcoma, glioma, glioblastoma, brain cancer, brain tumor, melanoma, lung cancer, follicular thyroid cancer, pancreatic cancer, anaplastic astrocytoma, bladder cancer, Patients with proliferative disorders selected from spinal dysplasia, prostate cancer, testicular cancer, lymphoma, leukemia, mycosis fungoides, head and neck cancer, breast cancer, ovarian cancer, colorectal and / or colon cancer or esophageal cancer Used to treat. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013521229-A |
priorityDate | 2007-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 572.